Hrvoje Roguljic
Overview
Explore the profile of Hrvoje Roguljic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bosnjak I, Bedekovic D, Selthofer-Relatic K, Roguljic H, Mihaljevic I, Dukic D, et al.
Front Cardiovasc Med
. 2024 Sep;
11:1458120.
PMID: 39346100
Introduction: The aim of this study was to investigate serum levels of galectin-3 (Gal-3) and N-terminal pro-brain Natriuretic Peptide (NT-proBNP) in patients with stable obstructive coronary artery disease, as well...
2.
Duspara K, Sikora R, Petrovic A, Roguljic L, Matic A, Kralik K, et al.
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541234
: Periodontitis is marked by the destruction of alveolar bone. Sclerostin (SOST) and dickkopf-1 (DKK-1) act as inhibitors of the Wingless-type (Wnt) signaling pathway, a key regulator of bone metabolism....
3.
Khaznadar F, Petrovic A, Khaznadar O, Roguljic H, Bojanic K, Roguljic L, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892698
In the current modern era of unhealthy lifestyles, non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease and has become a serious global health problem. To date, there...
4.
Kolaric T, Kuna L, covic M, Roguljic H, Matic A, Sikora R, et al.
Curr Issues Mol Biol
. 2023 May;
45(5):4246-4260.
PMID: 37232739
Liver fibrosis represents one of the greatest challenges in medicine. The fact that it develops with the progression of numerous diseases with high prevalence (NAFLD, viral hepatitis, etc.) makes liver...
5.
Bosnjak I, Bedekovic D, Selthofer-Relatic K, Roguljic H, Mihaljevic I, Bilic-Curcic I
BMC Cardiovasc Disord
. 2023 May;
23(1):268.
PMID: 37221462
Background: This study aimed to investigate the possible role of serum galectin-3 (Gal-3) levels in the diagnosis and assessment of significant epicardial artery lesions in patients with suspected coronary artery...
6.
Roguljic H, Arambasic J, Nincevic V, Kuna L, Sesto I, Tabll A, et al.
Croat Med J
. 2022 Jun;
63(3):287-294.
PMID: 35722697
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and mortality, which makes anticoagulation an integral part of treatment. However, pharmacodynamic and pharmacokinetic properties of direct...
7.
Kuna L, Zjalic M, Kizivat T, Roguljic H, Nincevic V, Kolaric T, et al.
Medicina (Kaunas)
. 2022 Jan;
58(1).
PMID: 35056399
Peptic ulcer disease is a chronic disease affecting up to 10% of the world's population. Proton pump inhibitors, such as lansoprazole are the gold standard in the treatment of ulcer...
8.
Roguljic H, Nincevic V, Bojanic K, Kuna L, Smolic R, Vcev A, et al.
Front Pharmacol
. 2021 May;
12:678546.
PMID: 34045969
Hepatitis C virus (HCV) infection is a systemic disease associated with multiple significant extrahepatic manifestations. Emerging studies indicate association between the HCV infection and a higher incidence of major adverse...
9.
Maric I, Kizivat T, Smolic M, Smolic R, Opacak-Bernardi T, Solic K, et al.
Acta Clin Croat
. 2020 Jan;
58(3):439-445.
PMID: 31969755
Patients with urolithiasis, particularly hypercalciuria, may have reduced bone mineral density (BMD). There are numerous risk factors contributing to reduction of BMD such as advanced age, sedentary lifestyle, smoking, low...
10.
Nincevic V, Kolaric T, Roguljic H, Kizivat T, Smolic M, Curcic I
Int J Mol Sci
. 2019 Nov;
20(23).
PMID: 31757028
Diabetic nephropathy (DN) is one of the most perilous side effects of diabetes mellitus type 1 and type 2 (T1DM and T2DM).). It is known that sodium/glucose cotransporter 2 inhibitors...